This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Zadnik V, Primic Žakelj M. SLORA: Slovenija in rak. Epidemiologija in register raka. Onkološki inštitut Ljubljana. Available Mar 25, 2017 from: www.slora.si.ZadnikVPrimic ŽakeljM.SLORA: Slovenija in rak. Epidemiologija in register rakaOnkološki inštitut LjubljanaMar 25, 2017www.slora.siSearch in Google Scholar
Cancer in Slovenia 2013. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2016.Cancer in Slovenia 2013. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia2016Search in Google Scholar
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-403.FerlayJSteliarova-FoucherELortet-TieulentJRossoSCoeberghJWComberHet al.Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012Eur J Cancer201349137440310.1016/j.ejca.2012.12.027Search in Google Scholar
Amaro J, Severo M, Vilela S, Fonseca S, Fontes F, La Vecchia C et al. Patterns of breast cancer mortality trends in Europe. Breast 2013; 22: 244-53.AmaroJSeveroMVilelaSFonsecaSFontesFLa VecchiaCet al.Patterns of breast cancer mortality trends in EuropeBreast2013222445310.1016/j.breast.2013.02.007Search in Google Scholar
Zadnik V, Žagar T, Žakelj MP. Cancer patients’ survival: standard calculation methods and some considerations regarding their interpretation. Zdr Varst 2016; 55: 134-41.ZadnikVŽagarTŽakeljMP.Cancer patients’ survival: standard calculation methods and some considerations regarding their interpretationZdr Varst2016551344110.1515/sjph-2016-0012Search in Google Scholar
Altobelli E, Lattanzi A. Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol 2014; 45: 1785-92.AltobelliELattanziA.Breast cancer in European Union: an update of screening programmes as of March 2014 (review)Int J Oncol20144517859210.3892/ijo.2014.2632Search in Google Scholar
Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-86.Independent UK Panel on Breast Cancer ScreeningThe benefits and harms of breast cancer screening: an independent reviewLancet201238017788610.1016/S0140-6736(12)61611-0Search in Google Scholar
Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S et al. Benefits and harms of breast cancer screening: s systematic review. JAMA 2015; 314: 1615-34.MyersERMoormanPGierischJMHavrileskyLJGrimmLJGhateSet al.Benefits and harms of breast cancer screening: s systematic reviewJAMA201531416153410.1001/jama.2015.1318326501537Search in Google Scholar
Lousdal ML, Kristiansen IS, Møller B, Støvring H. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway. Eur J Public Health 2014; 24: 1017-22.LousdalMLKristiansenISMøllerBStøvringH.Trends in breast cancer stage distribution before, during and after introduction of a screening programme in NorwayEur J Public Health20142410172210.1093/eurpub/cku01524596400Search in Google Scholar
Anon. DORA v letu 2016 izpolnila vse zastavljene cilje širitve. Available Mar 25, 2017 from: http://dora.onko-i.si/novice/novica/article/142/index.html?cHash=d525be78f0fef15ce00576373dde5a8d.Anon. DORA v letu 2016 izpolnila vse zastavljene cilje širitve. Available Mar 25, 2017 fromhttp://dora.onko-i.si/novice/novica/article/142/index.html?cHash=d525be78f0fef15ce00576373dde5a8dSearch in Google Scholar
Cancer incidence in Slovenia 2001. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2004.Cancer incidence in Slovenia 2001LjubljanaInstitute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia2004Search in Google Scholar
Cancer in Slovenia 2010. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2013.Cancer in Slovenia 2010LjubljanaInstitute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia2013Search in Google Scholar
Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O et al. Effects of screening and systemic adjuvant therapy on ERspecific US breast cancer mortality. J Natl Cancer Inst 2014; 106: dju289.MunozDNearAMvan RavesteynNTLeeSJSchechterCBAlagozOet al.Effects of screening and systemic adjuvant therapy on ERspecific US breast cancer mortalityJ Natl Cancer Inst2014106dju28910.1093/jnci/dju289427102625255803Search in Google Scholar
Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M et al. Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study. Eur J Cancer 2015; 51: 2191-205.SantMChirlaque LopezMDAgrestiRSánchez PérezMJHolleczekBBielska-LasotaMet al.Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 studyEur J Cancer201551219120510.1016/j.ejca.2015.07.02226421822Search in Google Scholar
Cancer in Slovenia 2009. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2013.Cancer in Slovenia 2009LjubljanaInstitute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia2013Search in Google Scholar
Imkampe AK, Bates T. Improvements in breast cancer survival over time, related to adjuvant treatment and node status. Eur J Surg Oncol 2009; 35: 151-5.ImkampeAKBatesT.Improvements in breast cancer survival over time, related to adjuvant treatment and node statusEur J Surg Oncol200935151510.1016/j.ejso.2008.02.01018387777Search in Google Scholar
Taib NA, Akmal M, Mohamed I, Yip CH. Improvement in survival of breast cancer patients - trends over two time periods in a single institution in an Asia Pacific country, Malaysia. Asian Pac J Cancer Prev 2011; 12: 345-9.TaibNAAkmalMMohamedIYipCH.Improvement in survival of breast cancer patients - trends over two time periods in a single institution in an Asia Pacific country, MalaysiaAsian Pac J Cancer Prev2011123459Search in Google Scholar
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378: 1707-16.Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)DarbySMcGalePCorreaCTaylorCArriagadaRet al.Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trialsLancet201137817071610.1016/S0140-6736(11)61629-2Search in Google Scholar
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-717.Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet2005365168771710.1016/S0140-6736(05)66544-0Search in Google Scholar
Roder DM, de Silva P, Zorbas HM, Kollias J, Malycha PL, Pyke CM et al. Age effects on survival from early breast cancer in clinical settings in Australia. ANZ J Surg 2012; 82: 524-8.RoderDMde SilvaPZorbasHMKolliasJMalychaPLPykeCMet al.Age effects on survival from early breast cancer in clinical settings in AustraliaANZ J Surg201282524810.1111/j.1445-2197.2012.06114.x22776502Search in Google Scholar
Andersson Y, Frisell J, Sylvan M, de Boniface J, Bergkvist L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol 2010; 28: 2868-73.AnderssonYFrisellJSylvanMde BonifaceJBergkvistL.Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodesJ Clin Oncol20102828687310.1200/JCO.2009.24.500120458033Search in Google Scholar
Allemani C, Sant M, Weir HK, Richardson LC, Baili P, Storm H et al. Breast cancer survival in the US and Europe: a CONCORD highresolution study. Int J Cancer 2013; 132: 1170-81.AllemaniCSantMWeirHKRichardsonLCBailiPStormHet al.Breast cancer survival in the US and Europe: a CONCORD highresolution studyInt J Cancer201313211708110.1002/ijc.27725470673522815141Search in Google Scholar
Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J 2015; 19: 48-79.BodaiBITusoP.Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendationsPerm J201519487910.7812/TPP/14-241440358125902343Search in Google Scholar
